Stem cells are unique cells that are able to replenish themselves through self-renewal and can divide to produce differentiated cell types. There are therapies using the cells of the body to regrow parts of the body like damaged nerve or cardiac tissue. Stem Cell Bioprocessing is the knowledge of stem cells physiological activity in relation to their culture parameters, culture practices and the new technologies of stem cell manufacture for therapeutic use. Stem cell application may be the last hope for restoring organ function. The field of stem cell biology is growing rapidly and key findings emerge almost daily. Tissue engineering is remarkably multidisciplinary, bringing together cell and molecular biologists, biochemists, engineers, pharmacologists, physicians, etc. The potential of stem cell research for tissue engineering-based therapies and regenerative medicine clinical applications has become well established. Harnessing the immense therapeutic and research potential of stem cells, also development and manufacturing of a therapeutic stem cell product requires extensive quality control to ensure the identity, quality, and safety of the cells. Journal of Regenerative Medicine is a peer-reviewed scholarly journal and aims to publish the most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of regenerative medicine and making them available online freely without any restrictions or any other subscriptions to researchers worldwide. Journal of Regenerative Medicine focuses on the topics include regenerative medicine therapies, stem cell applications and tissue regeneration. JRGM is using quality and standard review process, also online manuscript submission and tracking systems. Review processing is performed by the editorial board members of Journal Regenerative Medicine or outside experts.